Small heat shock protein B8:from cell functions to its involvement in diseases and potential therapeutic applications
Marta Chierichetti Riccardo Cristofani Valeria Crippa Veronica Ferrari Marta Cozzi Elena Casarotto Paola Pramaggiore Laura Cornaggia Guglielmo Patelli Ali Mohamed Margherita Piccolella Mariarita Galbiati Paola Rusmini Barbara Tedesco Angelo Poletti
Small heat shock protein B8:from cell functions to its involvement in diseases and potential therapeutic applications
摘要
关键词
aggregation/autophagy/cancer/chaperone/chaperone-assisted selective autophagy/cognitive impairment/HSPB8/neuroinflammation/neuromuscular diseases/therapy分类
医药卫生引用本文复制引用
Marta Chierichetti,Riccardo Cristofani,Valeria Crippa,Veronica Ferrari,Marta Cozzi,Elena Casarotto,Paola Pramaggiore,Laura Cornaggia,Guglielmo Patelli,Ali Mohamed,Margherita Piccolella,Mariarita Galbiati,Paola Rusmini,Barbara Tedesco,Angelo Poletti..Small heat shock protein B8:from cell functions to its involvement in diseases and potential therapeutic applications[J].Neural Regeneration Research,2025,20(10):P.2872-2886,15.基金项目
supported by:Fondazione Telethon-Italy(No.GGP19128 to AP) （No.GGP19128 to AP）
Fondazione Cariplo-Italy(No.2021-1544 to RC) （No.2021-1544 to RC）
Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica(AriSLA)-Italy(No.MLOpathy to AP （AriSLA）
Target-RAN to AP) （）
Association Française contre les Myopathies-France(AFM Telethon No.23236 to AP) （AFM Telethon No.23236 to AP）
Kennedy’s Disease Association-USA(2018 grant to RC （）
2020 grant to MG) （）
Ministero dell’Universitàe della Ricerca(MIUR)-Italy(PRIN-Progetti di ricerca di interesse nazionale(No.2017F2A2C5 to AP （MIUR）
No.2022EFLFL8 to AP （）
No.2020PBS5MJ to VC （）
No.2022KSJZF5 to VC) （）
PRIN-Progetti di ricerca di interesse nazionale-bando 2022,PNRR finanziato dall’Unione europea-Next Generation EU,componente M4C2,investimento 1.1(No.P2022B5J32 to RC and No.P20225R4Y5 to VC) （No.P2022B5J32 to RC and No.P20225R4Y5 to VC）
CN3:RNA-Codice Proposta:CN_00000041 （）
Tematica Sviluppo di terapia genica e farmaci con tecnologia a RNA(Centro Nazionale di Ricerca-CN3 National Center for Gene Therapy and Drugs based on RNA Technology to AP) （Centro Nazionale di Ricerca-CN3 National Center for Gene Therapy and Drugs based on RNA Technology to AP）
Progetto Dipartimenti di Eccellenza(to DiSFeB) （to DiSFeB）
Ministero della Salute,Agenzia Italiana del Farmaco(AIFA)-Italy(Co_ALS to AP) （AIFA）
Universitàdegli Studi di Milano(piano di sviluppo della ricerca(PSR)UNIMI-linea B(to RC and BT). （piano di sviluppo della ricerca(PSR）
